摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

HSP-117 free base | 738562-73-7

中文名称
——
中文别名
——
英文名称
HSP-117 free base
英文别名
(2S,3S)-2-phenyl-N-[(5-propan-2-yl-2,3-dihydro-1-benzofuran-7-yl)methyl]piperidin-3-amine
HSP-117 free base化学式
CAS
738562-73-7
化学式
C23H30N2O
mdl
——
分子量
350.5
InChiKey
AESKGNAICHGTKF-VXKWHMMOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    26
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    33.3
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • Novel Method
    申请人:Ferrari Giulio
    公开号:US20140128395A1
    公开(公告)日:2014-05-08
    There is provided inter alia a compound which is an NK-1 receptor antagonist for use in the treatment or prevention of CNV. There is also provided a compound which is an NK-1 antagonist for use in the treatment of chemical burns of the eye particularly alkali burns of the eye. There is also provided a pharmaceutical composition for topical administration to the eye comprising an NK-1 antagonist and an antibiotic agent.
  • TREATMENT OF CORNEAL NEOVASCULARIZATION
    申请人:IRBM SCIENCE PARK S.p.A.
    公开号:US20180021327A1
    公开(公告)日:2018-01-25
    There is provided inter alia a compound which is an NK-1 receptor antagonist for use in the treatment or prevention of CNV. There is also provided a compound which is an NK-1 antagonist for use in the treatment of chemical burns of the eye particularly alkali burns of the eye. There is also provided a pharmaceutical composition for topical administration to the eye comprising an NK-1 antagonist and an antibiotic agent.
  • NK-1 ANTAGONISTS FOR USE IN THE TREATMENT OF OCULAR PAIN
    申请人:OSPEDALE SAN RAFFAELE S.R.L.
    公开号:US20210015834A1
    公开(公告)日:2021-01-21
    The invention relates to compounds, in particular NK-1 antagonists, for use in the treatment of ocular sensitivity and/or ocular pain.
  • US9782397B2
    申请人:——
    公开号:US9782397B2
    公开(公告)日:2017-10-10
查看更多